Friday 6 November 2026
Export RMD’s income statement to Excel — free account
ResMed Inc.
RMD Healthcare Medical Instruments & Supplies
ResMed Inc.’s revenue for fiscal 2026 (year ended June 2026) was $5.7 billion, up 9.85% from fiscal 2025.
- Revenue
- +5.93%
- EPS
- +23.1%
- Free cash flow
- −9.79%
- Total debt
- −38.9%
Quarter to September 2026, against a year earlier
232.28
7.03
−2.94%
Follow RMD
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
7 | 7 | 6 | 8 |
| 25.68% | 25.25% | 24.27% | 26.40% | ||
| 19.00% | 18.59% | 17.77% | 19.29% | ||
ROIC |
21.42% | 22.59% | 21.38% | 22.81% | |
Return on Tangible Assets |
47.40% | 46.33% | 43.38% | 57.17% | |
Average Days of Receivables |
66.64 | 65.83 | 66.90 | 61.92 | |
Free Cash Flow per Share |
12.18 | 11.95 | 11.19 | 11.11 | |
Free Cash Flow |
1,776.59 | 1,736.26 | 1,628.66 | 1,588.36 | |
Capital Expenditures |
(137.90) | (153.70) | (177.17) | (182.57) | |
| Other line items | |||||
Cash ROIC |
21.82% | 20.29% | 19.26% | 22.04% | |
Accounts Receivable Turnover |
5.85 | 5.81 | 5.72 | 6.10 | |
Accounts Payable Turnover |
8.99 | 8.59 | 7.50 | 7.59 | |
Inventory Turnover |
2.34 | 2.40 | 2.35 | 2.27 | |
Average Days of Payables |
43.21 | 46.83 | 51.21 | 52.53 | |
Days of Inventory on Hand |
159.10 | 156.23 | 156.80 | 167.32 | |
Tax Rate |
(0.18) | (0.20) | (0.21) | (0.21) | |
Research and Development Expense of Revenue |
6.50% | 6.52% | 6.69% | 6.83% | |
Selling, General and Administrative Expense of Revenue |
19.87% | 20.10% | 19.80% | 20.11% | |
Share Based Compensation of Revenue |
1.83% | 1.84% | 1.85% | 1.97% | |
Interest Coverage |
(246.54) | (100.28) | (37.80) | (36.25) | |
Operating CF/Net income |
1.29 | 1.24 | 1.19 | 1.11 | |
Depreciation/Fixed assets |
0.44 | 0.46 | 0.42 | 0.40 | |
Capex/Depreciation |
(0.56) | (0.58) | (0.73) | (0.77) | |
Revenue per Share |
37.01 | 38.10 | 38.85 | 40.09 | |
Operating CF per Share |
13.13 | 13.00 | 12.41 | 12.39 | |
Capex per Share |
(0.95) | (1.06) | (1.22) | (1.28) | |
Capex to Sales |
0.03 | 0.03 | 0.03 | 0.03 |
Columns are period end dates · fundamentals updated 5 Nov 2026